These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25554978)

  • 1. The emering role of helminths in treatment of the inflammatory bowel disorders.
    Szkudlapski D; Labuzek K; Pokora Z; Smyla N; Gonciarz M; Mularczyk A; Maluch P; Okopien B
    J Physiol Pharmacol; 2014 Dec; 65(6):741-51. PubMed ID: 25554978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helminths and harmony.
    Weinstock JV; Summers R; Elliott DE
    Gut; 2004 Jan; 53(1):7-9. PubMed ID: 14684567
    [No Abstract]   [Full Text] [Related]  

  • 3. [A review of the clinical progress on helminths and their derivative products in autoimmune disease].
    Wu X; Gao H; Duan S; Ding W; Yang X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Dec; 39(12):1132-1140. PubMed ID: 38140874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials of helminth therapy in autoimmune diseases: rationale and findings.
    Fleming JO; Weinstock JV
    Parasite Immunol; 2015 Jun; 37(6):277-92. PubMed ID: 25600983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human helminth therapy to treat inflammatory disorders - where do we stand?
    Helmby H
    BMC Immunol; 2015 Mar; 16():12. PubMed ID: 25884706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Of worms and men--Administration of helminth products as an innovative approach to treatment of autoimmune diseases].
    Sega Y; Versini M; Shoenfeld Y
    Harefuah; 2015 Jul; 154(7):428-31, 470, 469. PubMed ID: 26380461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome-transported microRNAs of helminth origin: new tools for allergic and autoimmune diseases therapy?
    Siles-Lucas M; Morchon R; Simon F; Manzano-Roman R
    Parasite Immunol; 2015 Apr; 37(4):208-14. PubMed ID: 25712154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helminths: a clinical review and update.
    Prickett KA; Ferringer TC
    Semin Cutan Med Surg; 2014 Sep; 33(3):128-32. PubMed ID: 25577852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect.
    Voldsgaard A; Bager P; Garde E; Åkeson P; Leffers AM; Madsen CG; Kapel C; Roepstorff A; Thamsborg SM; Melbye M; Siebner H; Søndergaard HB; Sellebjerg F; Sørensen PS
    Mult Scler; 2015 Nov; 21(13):1723-9. PubMed ID: 25698173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel regulatory macrophage induced by a helminth molecule instructs IL-10 in CD4+ T cells and protects against mucosal inflammation.
    Ziegler T; Rausch S; Steinfelder S; Klotz C; Hepworth MR; Kühl AA; Burda PC; Lucius R; Hartmann S
    J Immunol; 2015 Feb; 194(4):1555-64. PubMed ID: 25589067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing the use of biological therapy in patients with inflammatory bowel disease.
    Moss AC
    Gastroenterol Rep (Oxf); 2015 Feb; 3(1):63-8. PubMed ID: 25567472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recommendations from the Brazilian Society of Rheumatology on the diagnosis and treatment of intestinal parasitic infections in patients with autoimmune rheumatic disorders].
    Braz AS; de Andrade CA; da Mota LM; Lima CM
    Rev Bras Reumatol; 2015; 55(4):368-80. PubMed ID: 25583002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex host genetics influence the microbiome in inflammatory bowel disease.
    Knights D; Silverberg MS; Weersma RK; Gevers D; Dijkstra G; Huang H; Tyler AD; van Sommeren S; Imhann F; Stempak JM; Huang H; Vangay P; Al-Ghalith GA; Russell C; Sauk J; Knight J; Daly MJ; Huttenhower C; Xavier RJ
    Genome Med; 2014; 6(12):107. PubMed ID: 25587358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying the immunomodulatory components of helminths.
    Shepherd C; Navarro S; Wangchuk P; Wilson D; Daly NL; Loukas A
    Parasite Immunol; 2015 Jun; 37(6):293-303. PubMed ID: 25854639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunomodulatory parasitic worm product ES-62 reduces lupus-associated accelerated atherosclerosis in a mouse model.
    Aprahamian TR; Zhong X; Amir S; Binder CJ; Chiang LK; Al-Riyami L; Gharakhanian R; Harnett MM; Harnett W; Rifkin IR
    Int J Parasitol; 2015 Mar; 45(4):203-7. PubMed ID: 25666929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
    Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
    Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications.
    Versini M; Jeandel PY; Bashi T; Bizzaro G; Blank M; Shoenfeld Y
    BMC Med; 2015 Apr; 13():81. PubMed ID: 25879741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Strongyloides stercoralis infection protect against type 2 diabetes in humans? Evidence from Australian Aboriginal adults.
    Hays R; Esterman A; Giacomin P; Loukas A; McDermott R
    Diabetes Res Clin Pract; 2015 Mar; 107(3):355-61. PubMed ID: 25656764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effects of Trichinella spiralis-derived excretory-secretory antigens.
    Radovic I; Gruden-Movsesijan A; Ilic N; Cvetkovic J; Mojsilovic S; Devic M; Sofronic-Milosavljevic L
    Immunol Res; 2015 Mar; 61(3):312-25. PubMed ID: 25616617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protists protecting food tolerance.
    Komnick MR; Esterházy D
    Trends Immunol; 2023 Oct; 44(10):745-747. PubMed ID: 37591713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.